Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

PATH is advancing health equity around the world

June 7, 2024
Medical oxygen in the spotlight: What can be done to improve access for good?
May 30, 2024
A day with co-creators exhibiting inclusive innovation in Kenya
May 29, 2024
Lessons from Malawi's collaborative approach to digital health

Stay informed with PATH Insights

Featured Press Coverage

February 8, 2024
Good intentions, bad outcomes: The dangers of donated medical devices
Devex
April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. These Brazilian besties are inventing an mRNA vaccine as a gift to the world
    PATH’s vaccine development expertise is highlighted in this piece about two Brazilian scientists developing a “self-amplifying” mRNA vaccine with the potential to lower cost and increase access.
    Published: July 2022
  2. It took 35 years to get a malaria vaccine. Why?
    Ashley Birkett, PhD, Director of PATH’s Malaria Vaccine Initiative, is quoted in this piece on the world’s first malaria vaccine (RTS,S) and why it’s taken so long to develop.
    Published: May 2022
  3. Global leaders are preparing for the next pandemic with commitments to a proposed new fund for prevention and response
    Heather Ignatius, PATH’s Director of Policy and Advocacy, is quoted in this piece highlighting recent national commitments to a proposed global fund for outbreak prevention and response.
    Published: May 2022
  4. Opinion: 4 steps to stay ahead of antimicrobial resistance
    Lutz Hegemann, MD, PhD, PATH board member and President, Global Health, at Novartis, co-authored this Devex piece on the growing threat of antimicrobial resistance.
    Published: May 2022
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. PATH as a major sub-partner for USAID-funded STRIDES Activity
    PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. PATH e Bio-Manguinhos/Fiocruz firmam compromisso para impulsionar plataformas tecnológicas e aumentar a produção local
    Published: October 2024
    Announcement
  3. PATH shares topline results from a Phase 3 study of an injectable rotavirus vaccine candidate
    The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. PATH and Bio-Manguinhos/Fiocruz commit to boosting technological platforms and increasing local production
    Published: October 2024
    Announcement
  5. Unitaid and partners launch first-of-its-kind regional manufacturing initiative to improve access to medical oxygen in sub-Saharan Africa
    Published: October 2024
    Press Release
Next